Regard vs VisualDx
Regard and VisualDx both suggest diagnoses, from different inputs. Regard reads the full chart in the EHR, recommends diagnoses with an evidence chain and drafts documentation. The customers on its homepage are health systems, and HCC capture and denial prevention put the finance office at the table. The vendor's customer results, such as Sentara's 17% rise in CC/MCC capture, are its own case studies. Regard shows no price and offers a demo request.
VisualDx builds a differential from findings and patient context, then lets the clinician compare look-alikes against 50,000+ images sorted by skin tone and body site. A rash-heavy clinic or a clinician working alone is its natural buyer, and the pricing page shows Elite at $299.99 per year, Core at $249.99 per year and a quote for groups of two to five.
A health system's diagnosis and documentation program is a Regard purchase. A clinician or group wanting image-backed differentials is a VisualDx purchase.
Decision support · Reviewed November 2, 2026
When to pick each one
Regard
- Reads the whole chart, cites evidence per diagnosis
- ONC 2015 Cures Update certificate dated May 2, 2024
- Epic shown in its technology demo
VisualDx
- Differential builder with look-alike images
- Elite $299.99 per year for clinicians
- Skin-of-color atlas
Score
Each row shows points earned of points available under the published rubric.
Regard
9of 100
VisualDx
48of 100
| Dimension | Regard | VisualDx | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 0 / 12 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 1.7 / 5.6 | 0 / 5.6 | +1.7 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 1.9 / 4.8 | 0 / 4.8 | +1.9 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 0 / 21 | 14.7 / 21 | -14.7 |
| RCT / meta-analysis / systematic review | 0 / 9 | 9 / 9 | -9 |
| Funding & adoption signal | 3 / 12 | 8.4 / 12 | -5.4 |
| Pricing transparency | 1.3 / 2.5 | 2.5 / 2.5 | -1.2 |
| Years in market | 0 / 6 | 6 / 6 | -6 |
Scroll horizontally to see every column.
Pricing
Regard
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
VisualDx
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Core (education) | n/a | $249.99 | Shown as $39.99 or $20.83 per month, billed annually. Free trial length is not stated. Annual plans that auto-renew have a 30-day grace period for a full refund of the renewed fee. |
| Elite (clinicians) | n/a | $299.99 | Shown as $49.99 or $24.99 per month, billed annually. |
| Groups and Enterprise | n/a | n/a | Contact for pricing, including small groups of 2 to 5 users. |
Evidence
Regard
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
VisualDx
FDA decisions
No FDA decision cited in our research as of October 20, 2026.
Peer-reviewed
4 PubMed records name VisualDx.
- Early Perspectives on Utilization of a Clinical Decision Support Tool: A Mixed-Methods Study. (opens in new tab)
- Experiences, challenges and lessons while implementing a clinical decision support system in Botswana. (opens in new tab)
- Racial disparities in skin tone representation of dermatomyositis rashes: a systematic review. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Regard | VisualDx |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Epic | Not specified |
| Founded | n/a | 1999 |
| HQ | n/a | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.


